Clinical Efficacy of Rituximab Combined with CHOP Regimen Sequential or Non-Sequential Local Radiotherapy in Diffuse Large B-Cell Lymphoma

To probe the clinical efficacy of rituximab combined with cyclophosphamide, adriamycin, vincristine together prednisone regimen sequential or non-sequential local radiotherapy in patients stage III-IV diffuse large B-cell lymphoma. The data 126 high-risk lymphoma First Affiliated Hospital Hainan Medical University from January 2018 to December 2021 were retrospectively analyzed. Among them, group adopted regimen, addition and treated group. short-term long-term efficacy, adverse reactions immunoglobulin levels compared these three groups. In comparison group, total effective rate was elevated whole increased relative Spearman correlation analysis unveiled that negatively correlated serum M level after 4 courses 6 treatment. Rituximab is therapy, which can significantly promote high safety.